CHICAGO – Kanade Shinkai, M.D., Ph.D., an associate professor of clinical dermatology and residency program director at the University of California, San Francisco (UCSF), has been named the new editor in chief of JAMA Dermatology, the leading clinical dermatology journal from the JAMA Network.
The appointment was effective July 2018 when Shinkai replaced June K. Robinson, M.D., research professor of dermatology at Northwestern University Feinberg School of Medicine, Chicago, who held the editorship for 14 years.
Shinkai specializes in medical dermatology and inpatient dermatology consults. An area of research interest for her is understanding the prevalence and best management of skin signs in patients with polycystic ovary syndrome (PCOS). She also serves as clinical dermatologist for the UCSF Multidisciplinary Clinic for PCOS.
“My editorial team and I aspire to publish the best research supporting evidence-based dermatology care, to highlight new trends in our understanding of cutaneous disease, and to provide timely, insightful and practical information for practicing clinicians. We also hope to expand the educational reach of the journal with enhanced educational features,” Shinkai said.
Shinkai, who earned her medical degree at UCSF, is interested in medical education and she teaches at the undergraduate medical, graduate medical and continuing medical education levels. She also serves on the board of directors for the Association of Professors of Dermatology and Society of Dermatology Hospitalists.
“I am pleased to welcome Dr. Kanade Shinkai to JAMA Dermatology and the JAMA Network family,” JAMA and JAMA Network Editor in Chief Howard Bauchner, M.D., said. “Kanade’s clinical and research expertise will serve her well in her new role as editor in chief of JAMA Dermatology. JAMA Dermatology has thrived under the excellent leadership of June Robinson – who, of course, we thank for her many years of service – and we expect that Kanade will carry on in the tradition of outstanding leadership.”
Robinson called editing JAMA Dermatology “one of the most rewarding parts of my career” and said she was confident the journal would evolve under Shinkai’s direction.
“Being at the center of worldwide dermatology gave me a deep appreciation for the scope of dermatology, the amazing dedication of dermatologists, and the suffering of patients afflicted with dermatologic conditions. It has been a rare privilege to touch so many lives. I am extremely fortunate to have had this experience,” Robinson said.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email email@example.com.